Kairos Pharma (KAPA) Q3 2025 Earnings

Aug 12Confirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.07
-0.05
-0.04
-0.02

Details

Expected EPS
-0.07
Actual EPS
-0.065
Surprise EPS
0.01
Surprise Percent
+7.14%

Description

⁨Kairos Pharma⁩ (⁦KAPA⁩) has reported earnings of ⁦-0.065⁩ per share for ⁦Q3 2025⁩.

0 Comments

Share your thoughts